Oleacein Intestinal Permeation and Metabolism in Rats Using an In Situ Perfusion Technique

dc.contributor.authorLópez-Yerena, Anallely
dc.contributor.authorPérez Bosch, Maria
dc.contributor.authorVallverdú i Queralt, Anna
dc.contributor.authorMiliarakis, Eleftherios
dc.contributor.authorLamuela Raventós, Rosa Ma.
dc.contributor.authorEscribano Ferrer, Elvira
dc.date.accessioned2021-05-20T09:08:52Z
dc.date.available2021-05-20T09:08:52Z
dc.date.issued2021-05-12
dc.date.updated2021-05-20T09:08:52Z
dc.description.abstractOleacein (OLEA) is one of the most important phenolic compounds in extra virgin olive oil in terms of concentration and health-promoting properties, yet there are insufficient data on its absorption and metabolism. Several non-human models have been developed to assess the intestinal permeability of drugs, among them, single-pass intestinal perfusion (SPIP), which is commonly used to investigate the trans-membrane transport of drugs in situ. In this study, the SPIP model and simultaneous luminal blood sampling were used to study the absorption and metabolism of OLEA in rats. Samples of intestinal fluid and mesenteric blood were taken at different times and the ileum segment was excised at the end of the experiment for analysis by LC-ESI-LTQ-Orbitrap-MS. OLEA was mostly metabolized by phase I reactions, undergoing hydrolysis and oxidation, and metabolite levels were much higher in the plasma than in the lumen. The large number of metabolites identified and their relatively high abundance indicates an important intestinal first-pass effect during absorption. According to the results, OLEA is well absorbed in the intestine, with an intestinal permeability similar to that of the highly permeable model compound naproxen. No significant differences were found in the percentage of absorbed OLEA and naproxen (48.98 ± 12.27% and 43.96 ± 7.58%, respectively).
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec712142
dc.identifier.issn1999-4923
dc.identifier.pmid34068871
dc.identifier.urihttps://hdl.handle.net/2445/177472
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pharmaceutics13050719
dc.relation.ispartofPharmaceutics, 2021, vol. 13, num. 5, p. 719
dc.relation.urihttps://doi.org/10.3390/pharmaceutics13050719
dc.rightscc-by (c) López-Yerena, Anallely et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
dc.subject.classificationMetabolisme
dc.subject.classificationPermeabilitat
dc.subject.classificationIntestins
dc.subject.classificationOli d'oliva
dc.subject.otherMetabolism
dc.subject.otherPermeability
dc.subject.otherIntestines
dc.subject.otherOlive oil
dc.titleOleacein Intestinal Permeation and Metabolism in Rats Using an In Situ Perfusion Technique
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
712142.pdf
Mida:
1.54 MB
Format:
Adobe Portable Document Format